Azenta Life Sciences Appoints New Multiomics President

Azenta Life Sciences announced a leadership transition, appointing Trey Martin as the new President of its Multiomics business, effective April 6, 2026. This strategic move is intended to accelerate the company's gene synthesis strategy and multiomics execution. Martin's appointment is expected to drive innovation and growth within this key business segment. The transition signals Azenta's commitment to advancing its capabilities in life sciences research and development.